Goldman Sachs
RMD icon

Goldman Sachs’s ResMed RMD Stock Holding History

Goldman Sachs’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-200
Closed -$17K – 6315
2017
Q4 		$17K Hold
200
– – ﹤0.01% 6137
2017
Q3 		$15K Sell
200
-7,800
-98% -$597K ﹤0.01% 6472
2017
Q2 		$623K Buy
+8,000
New +$572K ﹤0.01% 4897
2017
Q1 		– Sell
-1,000
Closed -$62K – 6965
2016
Q4 		$62K Buy
1,000
+300
+43% +$18.4K ﹤0.01% 6327
2016
Q3 		$45K Sell
700
-800
-53% -$53.3K ﹤0.01% 6511
2016
Q2 		$95K Sell
1,500
-200
-12% -$11.8K ﹤0.01% 6155
2016
Q1 		$98K Sell
1,700
-2,500
-60% -$142K ﹤0.01% 6076
2015
Q4 		$225K Sell
4,200
-4,300
-51% -$242K ﹤0.01% 5604
2015
Q3 		$433K Sell
8,500
-32,300
-79% -$1.74M ﹤0.01% 5298
2015
Q2 		$2.3M Buy
40,800
+38,000
+1,357% +$2.4M ﹤0.01% 3702
2015
Q1 		$201K Sell
2,800
-2,500
-47% -$162K ﹤0.01% 6017
2014
Q4 		$297K Buy
5,300
+300
+6% +$15.7K ﹤0.01% 5787
2014
Q3 		$246K Sell
5,000
-80,200
-94% -$4.08M ﹤0.01% 5961
2014
Q2 		$4.31M Buy
85,200
+2,900
+4% +$144K ﹤0.01% 3217
2014
Q1 		$3.68M Buy
82,300
+42,300
+106% +$1.9M ﹤0.01% 3383
2013
Q4 		$1.88M Sell
40,000
-17,600
-31% -$891K ﹤0.01% 4129
2013
Q3 		$3.04M Buy
57,600
+27,600
+92% +$1.34M ﹤0.01% 3480
2013
Q2 		$1.35M Buy
+30,000
New +$1.42M ﹤0.01% 4122

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs's RMD Position: Q1 2026 in Review

Goldman Sachs increased its ResMed (RMD) stake by 2.5% in Q1 2026, buying an estimated $6.18M and bringing the position to 1,004,205 shares worth $225M. The position accounts for 0.03% of the portfolio, ranked #628.

Goldman Sachs first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $236M in Q4 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Goldman Sachs held 1,004,205 shares of ResMed worth $225M as of Q1 2026.
  • Goldman Sachs bought 24,786 ResMed shares in Q1 2026, an estimated $6.18M.
  • ResMed made up 0.03% of Goldman Sachs's portfolio in Q1 2026, its #628 holding.
  • Goldman Sachs first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's ResMed position peaked at $236M in Q4 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.